ISCAID & IFRRS PROGRAMME Sunday 16th Oct 2016 ISCAID & IFRRS 17.00‐21.30 Registration 18.00 ‐18.15 Welcome & Tribute to Marian Horzinek 18.15‐19.00 Symposium opening keynote lecture: Novel strategies for vaccine development Adrian VS Hill (UK) 19.00‐21.30 Welcome drinks & light buffet – please take this time to view the posters Monday 17th Oct 2016 ISCAID & IFRRS Postgraduate student (incl. resident) breakfast in Walter's Restaurant for postgraduates staying in Bristol Marriott Royal Hotel 8.45‐9.40 ISCAID business meeting (all free to attend) 9.40‐9.45 Introduction & Welcome 9.45‐10.25 What's the value of comparative feline research? Margaret Hosie (UK) 10.25‐11.00 BREAK ISCAID IFRRS 11.00‐11.45 The kidneys & infections in dogs & Programmed death molecules in chronic viral infection Jessica Quimby (USA) Dorothee Bienzle (Can) 11.45‐11.57 ABSTRACT IO‐1 : a prospective multi‐national study on viral epidemiology, ABSTRACT RO‐1 Feline immunodeficiency in a dual‐host system: implications for lentiviral diversity and vaccine cross‐reactivity Afonso emergence Malmberg 11.57‐12.10 ABSTRACT IO‐2 Felis catus gammaherpesvirus 1 is a panlymphotropic gammaherpesvirus ABSTRACT RO‐2 Dynamics of two feline in the North American mountain lion McLuckie (Puma concolor) Kraberger 12.10‐14.00 LUNCH 14.00‐14.12 ABSTRACT IO‐3 Cryptic aspergillus species causing feline aspergillosis: how many hidden ABSTRACT RO‐3 The protective rate of the feline immunodeficiency virus vaccine: an Australian pathogens are there? Hubka field study Westman 14.12‐14.24 ABSTRACT IO‐4 Leucocyte populations in the sino‐nasal mucosa of cats with upper respiratory ABSTRACT RO‐4 The duration of antibody response following primary vaccination against feline tract aspergillosis Whitney immunodeficiency virus Westman 14.24‐14.36 ABSTRACT IO‐5 Environmental prevalence of pathogenic cryptic aspergillus species in Australia ABSTRACT RO‐5 Investigating the role of target cell availability in the pathogenesis of feline Talbot immunodeficiency virus infection Techakriengkrai 14.40‐15.25 Keynote lecture: CD8+ T cell dysfunction in FIV, CD8+ T cell epigenetics & micro‐RNAs Jonathan Fogle (USA) 15.25‐15.55 BREAK 15.55‐16.08 ABSTRACT IO‐6 Targeted enrichment for broad multiplex pathogen detection and sequencing ABSTRACT RO‐6 Immunopathologic effects of prednisolone and cyclosporine a on replication Lee and persistence of feline immunodeficiency virus Miller 16.08‐16.20 ABSTRACT IO‐7 Three cases of feline leptospirosis Murphy ABSTRACT RO‐7 Evaluation of quantitative FeLV p27 ELISA and real‐time PCR for staging and monitoring FeLV infections Beall ISCAID & IFRRS 16.20‐17.05 Feline leukaemia virus – new advances in diagnosis Regina Hofmann‐Lehmann (Switz) 17.05‐17.10 Concluding remarks 17.10‐18.15 Viewing of posters with authors; drinks will be served Tuesday 18th Oct 2016 ISCAID & IFRRS CLINICIAN DAY 8.55‐9.00 Introductory remarks Welcome & Registration 9.00‐9.40 Evolution of parvoviruses in dogs & cats FIP – dilemmas in diagnosis Alan Radford (UK) Séverine Tasker (UK) 9.40‐10.20 Genotyping toxoplasma – what's the importance? Feline retroviral infections – choosing the best point of care test Vanessa Barrs (Aus) Katrin Hartmann (Ger) 10.20‐11.00 BREAK 11.00‐11.40 Update on diagnosis of canine leishmaniosis in the era of vaccines Leptospirosis ‐ what's new? Laia Solano‐Gallego (Spain) for Leish Vet Barbara Kohn (Ger) 11.40‐12.20 Prevention of canine leishmaniosis in the era of vaccines What does a positive stool culture mean? Gaetano Oliva (Ita) Guadalupe Miro (Spain) for Leish Vet Ed Hall (UK) 12.20‐14.00 LUNCH 14.00‐14.30 ABSTRACT IO‐8 A multipronged pharmacologic attack on feline infectious peritonitis Bite‐sized update: What's new with the management of feline Murphy ABSTRACT IO‐9 Upregulation of endothelial adhesion molecules by the feline infectious gastrointestinal protozoal diseases (Cryptosporidium, Cystoisospora, Giardia peritonitis virus Acar & Tritrichomonas foetus)? Michael Lappin (USA) 14.30‐15.00 ABSTRACT IO‐10 Feline coronavirus shedding in cats with and without feline infectious peritonitis Barker Bite‐sized update: What's new with ocular feline herpesvirus? ABSTRACT IO‐11 Clostridium perfringens NetE and NetF toxin genes are associated with bloody David Maggs (USA) diarrhoea in dogs Leutenegger 15.00‐15.30 ABSTRACT IO‐12 Seroprevalence of Toxoplasma gondii and risk factors for exposure in Australian domestic cats Brennan Bite‐sized update: Diagnosis of respiratory tract infections ABSTRACT IO‐13 Risk factor analysis and prevalence of feline hepatozoonosis in Cypriot cats Lynelle Johnson (USA) using a novel PCR Attipa 15.30‐16.00 BREAK 16.00‐16.40 FIP – An update on pathogenesis of an enigmatic disease Appropriate use of antimicrobials in dogs & cats in practice Anja Kipar (Switz) Ian Battersby (UK) 16.40‐17.20 Management of upper respiratory infections in cats Feline lower urinary tract infections – when do they occur & how to manage Michael Lappin (USA) them Jessica Quimby (USA) 18.30‐22.30 SYMPOSIUM DINNER on SS GREAT BRITAIN Ferry transport from harbourside (behind Marriott Hotel) at 18.30 for dinner at 19.00; ferries return to harbourside at 22.30 Wednesday 19th Oct 2016 ISCAID IFRRS 9.10‐9.15 Introductory remarks 9.15‐10.00 Keynote lecture: Canine influenza virus – old & new Cynda Crawford (USA) 10.00‐10.12 ABSTRACT IO‐14 Serological survey of influenza A and B in dogs and cats in the united kingdom ABSTRACT RO‐8 Lifetime outcomes of feline immunodeficiency virus infection McCallum Afonso 10.12‐10.24 ABSTRACT IO‐15 Efficacy of canine parvovirus vaccines for puppies with maternally derived ABSTRACT RO‐9 Novel virus discovery in FIV‐associated lymphoma. Is there a needle in the antibody Sehata haystack? Aghazadeh 10.24‐10.36 ABSTRACT IO‐16 The molecular diagnosis of Pneumocystis canis pneumonia in dogs ABSTRACT RO‐10 Antibody response and immune cell phenotyping of feline foamy virus Danesi infection in domestic cats Ledesma‐Feliciano 10.36‐11.10 BREAK 11.10‐11.50 Angiostrongylus – where are we now? Impacts of chronic relatively apathogenic infections of cats – GHV, FFV, FIVs Eric Morgan (UK) Sue Vandewoude (USA) ISCAID & IFRRS 11.50‐12.30 Symposium closing keynote lecture: Deciphering the T‐cell immune response to HIV‐1 David Price (UK) 12.30‐14.00 PACKED LUNCH to take away at the end of the conference

Updated August 10, 2016